SCB-2023B

N/A

Report date: 2025/05/13 15:37:54

Base Information

Drug NameSCB-2023B
Drug Alias NameXBB.1.5-Adapted SARS-CoV-2 S-Trimer modulator therapy(Clover Biopharmaceuticals)SCB-2023BSCB-2023
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPhilippinesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesZhejiang Clover Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Clover Biopharmaceuticals Inc
Inactive CompaniesClover Biopharmaceuticals Aus Pty Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A